| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/20/2005 | US20050014258 Methods for altering cell fate |
| 01/20/2005 | US20050014256 Stem cell and dental pulp harvesting method and apparatus |
| 01/20/2005 | US20050014255 Stem cells for clinical and commercial uses |
| 01/20/2005 | US20050014254 Progenitor cell tissue from exocrine gland for use in regenerative and transplantion medicine; tissue egineering; tissue targeted therapy |
| 01/20/2005 | US20050014253 Culturing normal and malignant human bladder epithelial cells for use in regenerative medicine and tissue repair; tissue engineering; tissue matrices or matrix components for the surgical reconstruction of the genitourinary tract |
| 01/20/2005 | US20050014252 Apparatus comprising biodegradable matrix for use in storage and transfer of viable cells to mammals; tissue engineering; regenerative medicine |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014230 Generating immunoglobulin specific for human lymphadenopathy viral glycoprotein 120 for use in prevention and treatment of viral diseases; immunotherapy |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014220 Lectin-like domain of thrombomodulin and its therapeutic use |
| 01/20/2005 | US20050014210 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/20/2005 | US20050014209 Novel prostate cancer cell lines |
| 01/20/2005 | US20050014207 Monoclonal antibody hPAM4 |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050014150 Screening eukaryotic messenger RNA sequences and identifying internal ribosome entry site (IRES) elements for use in cap-independent expression of foreign genes in eukaryotic cells; enhancing in vitro translation heterologous |
| 01/20/2005 | US20050013870 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013808 Nitroreductase enzymes |
| 01/20/2005 | US20050013807 In vitro cultured skin tissue; HIF-1 alpha activity, stable under normoxic conditions; rapid vascularization; burns, wounds |
| 01/20/2005 | US20050013806 Culturing genetically altered stem cells on concave lens surface and placing onto cornea |
| 01/20/2005 | US20050013804 Using fibroblast growth factor containing medium; enhancing proliferation, maintaining pluripotency; claimed cells |
| 01/20/2005 | US20050013802 EB Matrix production from fetal tissue and its use for tissue repair |
| 01/20/2005 | DE10330216A1 Verwendung von Stammzellen aus Nabelschnurblut zur Verhinderung von Hirnschäden infolge Sauerstoffmangel und zur Neuroprotektion Use of stem cells from umbilical cord blood to prevent brain damage due to lack of oxygen and for neuroprotection |
| 01/20/2005 | CA2559791A1 Secreted proteins as markers for cell differentiation |
| 01/20/2005 | CA2558946A1 Novel method for the preparation of embryoid bodies (ebs) and uses thereof |
| 01/20/2005 | CA2534090A1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | CA2532173A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/20/2005 | CA2532038A1 Compositions and methods for stable isotope labelling of biological compounds |
| 01/20/2005 | CA2531962A1 Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 01/20/2005 | CA2531627A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations |
| 01/20/2005 | CA2531242A1 Method of altering cell properties by administering rna |
| 01/20/2005 | CA2531235A1 Applications of a new class of enzymes: sulfiredoxines. |
| 01/20/2005 | CA2531208A1 Novel immune booster compound comprising an ef adenoviral sequence |
| 01/20/2005 | CA2530529A1 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 01/20/2005 | CA2528669A1 Compositions and methods for treating and diagnosing cancer |
| 01/19/2005 | EP1498479A2 Non-myeloablative tolerogenic treatment |
| 01/19/2005 | EP1498478A1 Method of forming pancreatic beta cells from mesenchymal cells |
| 01/19/2005 | EP1498475A1 Continuous plant cell bioreactor and method for continuous plant cell culture |
| 01/19/2005 | EP1498428A1 Antibodies for detecting ecstasy-class analytes |
| 01/19/2005 | EP1498426A1 Preparation of fully human antibodies |
| 01/19/2005 | EP1498415A1 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/19/2005 | EP1498136A2 Non-myeloablative tolerogenic treatment |
| 01/19/2005 | EP1498026A2 Method and system for three-dimensionally imaging an apical dome of a plant embryo |
| 01/19/2005 | EP1498025A2 Automated system and method for harvesting and multi-stage screening of plant embryos |
| 01/19/2005 | EP1497634A2 Protein knobs |
| 01/19/2005 | EP1497470A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 01/19/2005 | EP1497468A1 Cells for detection of influenza and parainfluenza viruses |
| 01/19/2005 | EP1497457A1 Method and kit for detecting membrane protein-protein interactions |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497444A2 Methods for increasing polypeptide production |
| 01/19/2005 | EP1497440A2 Stable adenoviral vectors and methods for propagation thereof |
| 01/19/2005 | EP1497435A2 Placental derived stem cells and uses thereof |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497415A2 Cytokine receptor |
| 01/19/2005 | EP1497414A1 Rapid generation of activated mononuclear antigen presenting cells from monocytes |
| 01/19/2005 | EP1497413A1 Methods for producing immortalised antibodies-secreting cells |
| 01/19/2005 | EP1497412A2 Adenovirus vectors for immunotherapy |
| 01/19/2005 | EP1497411A1 Embryo modification and implantation |
| 01/19/2005 | EP1497410A2 Cellular transplantation for heart regeneration |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497332A1 Bispecific antibody binding tcr and tirc7 and its use in therapy and diagnosis |
| 01/19/2005 | EP1497319A2 Cell adhesion and extracellular matrix proteins |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1496978A2 Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof |
| 01/19/2005 | EP1496943A2 Oligomeric compounds having modified phosphate groups |
| 01/19/2005 | EP1496935A2 Insulin and igf-1 receptor agonists and antagonists |
| 01/19/2005 | EP1496886A1 Knockout mice and their use |
| 01/19/2005 | EP1496824A2 Tissue composites and uses thereof |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1496737A2 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 01/19/2005 | EP1404812A4 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1320617A4 Genetic engineering of syringyl-enriched lignin in plants |
| 01/19/2005 | EP1082071A4 Bioengineered flat sheet graft prostheses |
| 01/19/2005 | EP1070081A4 Novel molecules of the t129-related protein family and uses thereof |
| 01/19/2005 | EP0804074B1 Treating red blood cell solutions with anti-viral agents |
| 01/19/2005 | EP0789588B1 Method for making a medicament for treating secondary immunodeficiency |
| 01/19/2005 | EP0680517B2 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
| 01/19/2005 | EP0545946B1 Growth-promoting agent |
| 01/19/2005 | CN1568374A Method for identifying compounds modulating reverse cholesterol transport |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568194A Modulation of smooth muscle cell proliferation |
| 01/19/2005 | CN1566951A Cell sorting method based on micro flow control chips and special-purpose chips therefor |
| 01/19/2005 | CN1566342A Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 01/19/2005 | CN1566339A Device for making microencapsulation cell |
| 01/19/2005 | CN1566333A Method for cryopreservation of cell |
| 01/19/2005 | CN1566332A Method for in vitro induction of embryonic stem cell to differentiate into myocardial cell |
| 01/19/2005 | CN1566331A Serum-free culture medium for lymphocyte |
| 01/19/2005 | CN1566330A Activated HLA semi-coincident allogene mixed hematopoietic stem cell and method for making same |
| 01/19/2005 | CN1566134A Non-structural protein gene of coronavirus and use thereof |
| 01/19/2005 | CN1566114A Novel psoralen derivative for annihilating live virus or germ |
| 01/19/2005 | CN1565650A Tissue vascularization promoting gene-chitosan nanometer granula complex |
| 01/19/2005 | CN1565649A Manufacturing method of bracket material for applying in myocardial tissue engineering |